Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
42.39
Nov 06 • 3:59 PM ET Dollar change+2.52 Percentage change(6.32%)
Aftermarket Close
42.39
Aftermarket • 7:30 PM ET Dollar change0.00 Percentage change(0.00%)
Nov 06, 4:42 PMGuardian raises 2026 guidance as margins expand despite IRA-related revenue headwinds
Index
RUT
Market Cap
2.68B
Enterprise Value
2.61B
Income
74.77M
Sales
1.46B
Book/sh
4.22
Cash/sh
1.89
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
3600
IPO
Sep 26, 2024
P/E
36.15
Forward P/E
28.75
PEG
1.87
P/S
1.84
P/B
10.05
P/C
22.44
P/FCF
27.92
EV/EBITDA
22.57
EV/Sales
1.79
Quick Ratio
1.33
Current Ratio
1.65
Debt/Eq
0.13
LT Debt/Eq
0.10
Option/Short
Yes / Yes
EPS (ttm)
1.17
EPS next Y
1.47
EPS next Q
0.44
EPS this Y
26.03%
EPS next Y
9.32%
EPS next 5Y
15.34%
EPS past 3/5Y
10.88% 31.17%
Sales past 3/5Y
16.81% 16.29%
EPS Y/Y TTM
83.17%
Sales Y/Y TTM
4.85%
EPS Q/Q
88.82%
Sales Q/Q
-1.68%
Insider Own
66.73%
Insider Trans
0.00%
Inst Own
46.56%
Inst Trans
1.96%
ROA
16.96%
ROE
33.16%
ROIC
25.33%
Gross Margin
22.45%
Oper. Margin
6.34%
Profit Margin
5.13%
SMA20
5.26%
SMA50
2.38%
SMA200
10.44%
Trades
Shs Outstand
63.32M
Shs Float
21.07M
52W High
48.33 -12.29%
52W Low
26.34 60.93%
Volatility
5.01% 3.77%
ATR (14)
1.71
RSI (14)
56.53
Beta
0.13
Rel Volume
2.12
Avg Volume
512.30K
Volume
1,085,553
Perf Week
4.18%
Perf Month
1.90%
Perf Quarter
2.22%
Perf Half Y
17.46%
Perf YTD
40.88%
Perf Year
48.79%
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Prev Close
39.87
Price
42.39
Change %
6.32%
Consensus
Strong Buy
Avg. Price Target
$50.14
Implied Upside
+18.3%
Analysts6incl. previous ratings
Rating Distribution6 Buy · 0 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Sep 23, 2026Initiated
KEY logoKKeyBanc Capital Markets
Overweight$52+22.7%
Apr 27, 2026Initiated
BAC logoBBofA Securities
Buy$42-0.9%
Mar 30, 2026Initiated
JEF logoJJefferies
Buy$44+3.8%
Oct 10, 2025Initiated
OPY logoOOppenheimer
Outperform$30-29.2%
Oct 21, 2024Initiated
TFC logoTTruist
Buy$22-48.1%
Oct 21, 2024Initiated
RJF logoRRaymond James
Outperform$21-50.5%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pharmacy Investors, LLCMember of 10% owner groupMar 20 '26Sale29.68827,63624,566,3061,035,928Mar 24 04:15 PM
Morris David KSee RemarksMar 20 '26Sale29.68187,8555,576,006254,472Mar 24 04:15 PM
Burke FredSee RemarksMar 20 '26Sale29.68671,43219,929,780840,413Mar 24 04:15 PM
Forbes KendallSee RemarksMar 20 '26Sale29.68346,67210,290,092453,256Mar 24 04:15 PM
Cardinal Equity Fund, L.P.Member of 10% owner groupMar 20 '26Sale29.68275,7288,184,296345,123Mar 24 04:15 PM
Salentine Thomas J JrDirectorMar 20 '26Sale29.683,570,677105,986,6204,469,316Mar 24 04:15 PM
Bindley Capital Partners I, LL10% OwnerMar 20 '26Sale29.683,570,677105,986,6204,469,316Mar 24 04:15 PM
Ackerman JohnDirectorMar 20 '26Sale29.681,103,36432,750,602345,123Mar 24 04:15 PM
BINDLEY WILLIAM EDirectorMar 20 '26Sale29.683,570,677105,986,6204,469,316Mar 24 04:15 PM
COSLER STEVEN DDirectorDec 03 '25Buy29.613,37099,78624,984Dec 05 04:10 PM
Guardian Pharmacy Services, Inc. engages in the provision of client service and resident care to long-term care communities. It offers assisted living and skilled nursing, group homes, behavioral health and organizations that serve individuals with intellectual and developmental disabilities. The company was founded by Fred P. Burke, David Morris, and Kendall Forbes on July 21, 2003 and is headquartered in Atlanta, GA.
CEOMr. Fred P. Burke
COO & DirectorMr. David K. Morris
Senior VP & CFOMr. Will Mudd CPA
Senior VP of TechnologyMr. David Martin
Head of Investor Relations & Senior DirectorMs. Ashley Stockton